Results 171 to 180 of about 186,128 (186)

Economic Evaluations of Medical Care Interventions for Cancer Patients: How, Why, and What Does it Mean?

Ca-A Cancer Journal for Clinicians, 2008
Ya-Chen Tina Shih
exaly  

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Nature Reviews Drug Discovery, 2019
Jerome Galon, Daniela Bruni
exaly  

Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial

Lancet, The, 2018
Michael Doherty, Aliya Sarmanova, Abhishek Abhishek   +2 more
exaly  

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

Lancet, The, 2014
Eric Lawitz, Mark S Sulkowski, Zobair M Younossi   +2 more
exaly  

Targeting the Nogo Receptor to Treat Central Nervous System Injuries

Nature Reviews Drug Discovery, 2003
Stephen M Strittmatter
exaly  

From effect size into number needed to treat

Lancet, The, 1999
Toshi A Furukawa
exaly  

Tobacco Control for Clinicians Who Treat Adolescents

Ca-A Cancer Journal for Clinicians, 2003
exaly  

T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma

Cancer Cell, 2015
Ingunn M Stromnes, Thomas M Schmitt, Philip D Greenberg   +2 more
exaly  

New tricks to treat Ebola

Nature Reviews Drug Discovery, 2016
Megan Cully
exaly  

Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer

Nature Reviews Drug Discovery, 2007
exaly